Carnot Laboratories Carnot is celebrating 70 years as a company. There have been a lot of changes over this time, but more specifically over the last three to four years, please can you describe to us in your own words the evolution of the Mexican pharmaceutical industry, and the most impactful changes…
Within the Ministry’s wide scope of activities aimed at promoting Turkish various industries and trade, what special role does the pharmaceutical sector play within these aspirations? The world we live in today is so a globalized that only the societies, which produce knowledge/information and are able to transform this knowledge…
Focus Reports has been here a bit more than three months, and heard different opinions. Some said highlighted Turkey’s strategic advantages – population, age distribution, geography, political and economic stability -, while some were much more cautious when assessing Turkey’s market situation, potential for exports, and potential to develop as…
Would you like to provide our international readers with a brief introduction into Novo Nordisk’s Turkish affiliate? As you may know, Novo Nordisk has a rich history of over 85 years of experience across the globe where we now treat more than 24 million people with our advanced injectable treatments.…
You are managing partner of Egon Zehnder Turkey since 2007. Could you start by introducing the company to our readers and its scope of activities in Turkey? Egon Zehnder International is a global executive search firm. We have activities in more than 40 countries with around 65 offices. The Istanbul…
Cegedim has become a very strong partner for pharmaceutical companies worldwide, including Turkey. Nevertheless, with respect to healthcare, there are probably as many systems as countries. How does Cegedim adapt to the Turkish reality, and how different are your services compared to those in developed markets? Cegedim is a flexible…
After a significant experience in consumer goods at Procter & Gamble, you have been managing director of Janssen Turkey for 11 years. Over this last decade, the Turkish pharma market has fundamentally changed in its structure—with the introduction of the NHI, a reference pricing system, institutional discounts, new patent laws,…
Omega CRO was the first clinical trial company in Turkey. A few years later, in 2002, we saw a sharp increase of similar businesses, including Quintiles. What spurred the establishment of Quintiles in Turkey? In terms of presence, Quintiles was in fact the first in the market in 1996, with…
AIFD - Association of Research-Based Pharmaceutical Companies Pharmaceutical Executive and Focus Reports are of course about the industry but also about the people making it happen. So before anything would you like to introduce yourself to our readers and expose the career path that has led you to take the helm of Turkey’s leader in the pharmaceutical…
AIFD - Association of Research-Based Pharmaceutical Companies In an environment where the line between generic and innovator companies is less and less relevant, due to the growing trend of innovators integrating generics products in their portfolio through acquisitions, to what extent has the role of association evolved? Despite the growing trend of integrating innovative products with generics,…
MSD Czech Republic Dr. Novotný, in 2008, you became Managing Director for MSD for the Czech and Slovak Republics. In the very next year after your appointment, you were tasked with managing the merger between MSD and Schering-Plough. How challenging was this undertaking, and what were the keys to its success? This was…
See our Cookie Privacy Policy Here
